Company Search:
Advanced Search
Sponsored Links
Innate Pharma S.A. Company Snapshot
Innate Pharma S.A. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Innate Pharma S.A. with three other companies in this sector in France: Oncodesign Sa (2017 sales of 14.41 million Euro [US$17.81 million] ), Cellectis SA (29.60 million Euro [US$36.58 million] ), and GeNeuro SA (14.70 million Euro [US$18.17 million] ).

Sales Analysis. Innate Pharma S.A. reported sales of 32.63 million Euro (US$40.33 million) for the year ending December of 2017. This represents a sharp decrease of 41.9% versus 2016, when the company's sales were 56.16 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Innate Pharma S.A.
  Stock Performance Chart for Innate Pharma S.A.
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 5.44
(Figures in Euro)
1 Week -2.9%   13 Weeks -2.1%  
4 Weeks 17.0%   52 Weeks -53.4%  
Innate Pharma S.A. Key Data:
  Ticker: IPH Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 32,631,000
(Year Ending Jan 2018).
Employees: 154
  Currency: Euro Market Cap: 293,230,846
  Fiscal Yr Ends: December Shares Outstanding: 53,902,729
  Share Type: Actions Ordinaires Closely Held Shares: 10,661,364
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.